The postdoctoral researcher will contribute to this project using
a combination of evolutionary and comparative genomics, as well as a
diverse set of bioinformatic approaches for data analysis and integration
(e.g., transcriptomics, genomics, phenotypic data). This position offers
a unique opportunity to integrate diverse state-of-the-art genomic and
phenotypic datasets across different model organisms to understand the
role of genes, molecular pathways in the origin of complex diseases.

CINV provides a highly collaborative and multidisciplinary environment
using a variety of computational and experimental approaches,
including genetically tractable animal models as well as expertise in
genetics, behavior, glia-neuron communication, metabolism, biophysics,
genomics, bioinformatics, host-microbe communication, and biomolecular
modelling. The new postdoc will be part of one of our labs which focuses
more generally on the intersection between molecular evolution and
disease biology.

Required qualifications are a PhD in evolutionary biology, computational
biology, bioinformatics, or closely related fields. Candidates must have
excellent verbal and written communication skills (working language
is English), as well as an established record of productivity (e.g.,
at least one previous peer-reviewed publication). Candidates with a
past record of publications in bioinfomatics, computational biology,
population genetics or evolutionary genomics are strongly preferred. Ideal
candidates should have experience in analyzing genomic and phenomic
data, performing comparative evolution or population genomic analyses,
as well as in collaborating with experimentalists.

Interested candidates should first contact Evandro Ferrada at
. Please include the following: (1) a cover
letter addressing your interest in the position and how your expertise
meets the position requirements, (2) a CV, (3) contact information of
at least 2 references. A short online interview will follow to discuss
specific proposals. Candidate materials will be reviewed as soon as
possible until the position is filled.

For further information, please visit:
https://cinv.uv.cl/cinv-postdoctoral-fellowship-program-2026/

Dr. Evandro Ferrada
Associate Profesor

Centro Interdisciplinario de Neurociencia (CINV)

Facultad de Ciencias, Universidad de Valpara�so.

Pasaje Harrington 287, Playa Ancha, Valpara�so, Chile.

Tel. +56 (32) 250 8453

www.cinv.cl

Modern sequencing technologies have turned biology into a data-heavy science. The human genome has about three billion DNA base pairs, and sequencing can produce massive datasets quickly. Bioinformatics helps organize and interpret this information, allowing scientists to compare genomes, find genes, spot genetic differences, study gene expression, and understand diseases at the molecular level. Now, AI is changing how these datasets are analyzed. Machine learning and deep learning can find complex patterns in biological data and make predictions using large datasets. Rather than following only set rules, AI systems can learn from data and help researchers solve tough biological problems.

A key example of AI in bioinformatics is predicting protein structures. Proteins are vital for many functions in living things, and their three-dimensional shapes are closely tied to what they do. For a long time, figuring out these structures in the lab was slow and difficult. AI-based tools like AlphaFold have shown that deep learning can predict protein structures with impressive accuracy. These advances help speed up biological research and give scientists useful predictions to support their experiments. This shift means bioinformatics is moving from just analyzing biological data to predicting how biology works and designing new solutions.

AI is also expected to greatly influence drug discovery. Traditionally, developing a new drug is a long and costly process that involves finding biological targets, searching for possible drug molecules, testing how well they work, studying their properties, and running many experiments. AI can help researchers analyze large chemical and biological datasets, predict how molecules might interact with targets, find promising compounds, and estimate properties of drug candidates. Generative AI can even help design new molecules to test in the lab. This does not mean lab experiments will go away, but AI can help researchers focus on the best options and possibly speed up some parts of drug development.

Personalized medicine is another area where AI-driven bioinformatics could make a big difference. Each person has a unique mix of genetic, molecular, environmental, and lifestyle factors, so people with the same disease might respond differently to the same treatment. Bioinformatics lets researchers study individual biological data, and AI can combine many types of information, like genetic data, gene expression, protein levels, medical images, clinical records, and drug responses. In the future, this could help doctors look beyond just the disease and focus on the specific biology of each patient. This would support more personalized ways to diagnose, assess risk, and choose treatments.

As AI becomes more common, the job of bioinformaticians will likely change. Instead of spending most of their time on repetitive computer tasks, they may focus more on creating research questions, understanding AI results, checking predictions, and linking computer findings to lab experiments. Future professionals will need to know about molecular biology, genetics, statistics, programming, machine learning, data science, databases, and computational biology. But technical skills alone will not be enough. Being able to ask good scientific questions and carefully judge computer results will be even more important, since AI can make predictions, but scientists must decide if those predictions make sense and can be proven in the lab.

Even with its great potential, using AI in bioinformatics comes with big challenges. AI systems rely on the quality and variety of the data they are trained on. Biological and clinical datasets can have missing information, technical errors, inconsistent measurements, and may not represent all groups equally. A model that works well on one dataset might not work as well on another group or in a different setting. That is why data quality, proper validation, transparency, reproducibility, and careful model development are crucial for the future of AI in bioinformatics. Researchers also need to think about genetic privacy, data ownership, security, and using personal biological information responsibly. These concerns are especially important when AI predictions are used in healthcare.

The lab of the future may look very different from today’s. Researchers might use AI to review scientific papers, find research questions, analyze large datasets, come up with ideas, and predict which experiments will be most helpful. Automated lab systems could then run these experiments, create new data, and send the results back to computer models. This would create a cycle of making guesses, predicting, experimenting, collecting data, and learning. This approach could speed up scientific discovery by helping researchers explore questions more efficiently. Bioinformatics could become a key link between computer predictions and real lab experiments.

In the end, the future of bioinformatics with AI will not be about replacing people with machines. It will be about humans and AI working together. Computers can handle huge amounts of biological data and spot patterns that a single person could not. But humans bring scientific understanding, creativity, critical thinking, ethical judgment, and the ability to see the bigger picture. AI might find a pattern in millions of genomes, but scientists need to figure out why it matters. An AI model could suggest a new drug, but researchers must check if it is safe and works well. A computer might find a genetic change, but doctors have to decide what it means for a real patient.

The future of bioinformatics is closely tied to the future of AI. As biological data grows and AI models get better, bioinformatics may shift from mainly analyzing data to predicting biological processes, designing new molecules, speeding up experiments, and supporting personalized healthcare. For students and researchers, this is an exciting chance to work where biology and technology meet. The most successful people will not just be those who use the latest AI tools, but those who understand biology well enough to ask good questions and judge the answers carefully. The future will not be about AI versus humans, but about people and AI working together to understand life in ways we never could before. The next big discovery may come from this partnership between a biological question, a computer model, a lab experiment, and human curiosity.

Conference

7th to 8th October 2013
Berlin, Germany

Website: https://www.gtcbio.com/conference/ngseurope-overview
Contact person: Kristen Starkey

We welcome you to join us at GTC’s NGS & Bioinformatics Summit Europe on October 7-8, 2013 in Berlin, Germany.

Organized by: GTC
Deadline for abstracts/proposals: 7th September 2013

Address of the bookmark: http://www.genengnews.com/keywordsandtools/print/3/32115/

Link @ http://bioinf.boku.ac.at/

• The market size of the Indian Bioinformatics Industry , FY’2007-FY’2013
• Market segmentation of India bioinformatics industry by application by sectors, FY’2007-FY’2013
• Market Segmentation of India bioinformatics industry by products and services,FY’2007-FY’2013
• Market Segmentation of India bioinformatics industry by applications of bioinformatics ,FY’2007-FY’2013
• India bioinformatics industry trends and developments
• Government regulations and initiatives of India bioinformatics industry
• Major bioinformatics research institutes in India
• Market Share of leading players in bioinformatics industry in India,FY’2013
• Company profiles of major players in India bioinformatics industry
• Future outlook and projections on the basis of revenue in India bioinformatics market, FY’2014-FY’2018

                                                                                                         (Source: Ken Research)

Address of the bookmark: http://www.kenresearch.com/healthcare/biotechnology/india-bioinformatics-industry-research-report/392-91.html

for applicants interested in performing high-quality research on the connection between software engineering, database systems, and theoretical computer science as well as their applications in bioinformatics and business informatics. The research programme will start on October 1, 2013 until 30.09.2016. The period of employment is governed by the Fixed Term Research Contracts Act (Wissenschaftszeitvertragsgesetz – WissZeitVG).

This research programme is a joint activity of Professors Lehner, Assmann, Baader, Baier, Schill, Schlegel, Schroeder, and Strahringer at TU Dresden. Alongside their research, an individual mentoring and qualification approach are arranged with specialized courses that prepare them optimally for their research, a research seminar where they can meet internationally renowned researchers in the field, and soft skills and language courses.

Requirements: Applicants should have an excellent academic record, and hold a MSc (or an equivalent university degree) in computer science or related disciplines (such as mathematics, bioinformatics or business informatics). Fluency in spoken and written English is required. Applicants with a good knowledge of software engineering or one of the application areas mentioned above are preferred. TU Dresden is committed to increase the proportion of women in research.

Applications from women are particularly welcome. The same applies to disabled people.

Please send enquiries to: wolfgang.lehner@tu-dresden.de

Applications consist of a CV, the names of two referees, transcipts of documents summarizing their academic performance, and a statement of interest. Application by email in pdf format is preferred, and should be submitted to wolfgang.lehner@tu-dresden.de in an electronically signed and encrypted form by July 30, 2013 (stamped arrival date of the university central mail service applies). Alternatively, applications can be sent to: TU Dresden, Fakultät Informatik, Institut für Systemarchitektur, Prof.  Dr.-Ing.  Wolfgang Lehner, 01062 Dresden, Germany.

Shortlisted candidates will be invited to Dresden in the middle of August to give a presentation on their Master’s thesis and discuss their research interest with the participating professors. Candidates that have not yet finished their degree when they send in their application should send preliminary transcripts of their academic records as well as a letter by the thesis adviser that comments on their progress so far and on the expected date of completion of their MSc or equivalent degree.

genomic scale studies
endogenous mechanisms of mutations, germ line and somatic
computational aspects of immunology in cancer
signalling networks
three-dimensional organization of information in the nucleus
gene silencing
metastatic cross-talk
kinase signaling
personalized medicine
detection of biomarkers in cancer
historical DNA variation

From : http://www.ous-research.no/hovig/

Group address:
Eivind Hovig, The Norwegian Radium Hospital, Montebello, 0310 Oslo,Norway
Email: ehovig@radium.uio.no